Sisram Medical Ltd (HK:1696), a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, announced on Tuesday the official launch of its Titanium Prime treatment concept in Hong Kong SAR.
Integrating two flagship EBD platforms, Alma PrimeX and Soprano Titanium Special Edition, the new concept expands the range of combined aesthetic solutions available locally and accelerates Sisram's strategic shift toward an integrated, multi-technology service delivery model.
Powered by Tri-Energy Synergy technology, Titanium Prime unites laser, radiofrequency, and ultrasound modalities via the exclusive BTS2 Methodology, a layered system engineered to target varying tissue depths and deliver multidimensional anti-ageing and skin rejuvenation outcomes. It leverages the complementary technical strengths of Alma PrimeX and Soprano Titanium Special Edition to focus on multi-layered tissue care spanning the epidermis, dermis, and subcutaneous layers. This approach helps to complement the diverse aesthetic needs of patients, including skin texture, firmness, and facial contours, Sisram said.
The rollout in Hong Kong SAR is expected to serve as a benchmark for tailoring localised combined treatment strategies across key APAC markets.
ProBio and Kun Tuo collaborate to deliver integrated CDMO-CRO solutions for advanced therapies
Myosin Therapeutics chosen for 2026-2027 NCI Investor Initiatives Showcase
Medtronic receives FDA clearance for LigaSure RAS Maryland instrument on Hugo system
Aptar and Aceso Therapeutics partner to advance inhaled cystic fibrosis therapy
Tempus announces receipt of FDA clearance for AI pulmonary hypertension detection product
Pulnovo Medical commences enrolment in PULSE-LHD IDE clinical trial
Implantica's RefluxStop receives US FDA approval
Sectra to provide Education Portal to Loyalist College for medical imaging training
Aqua Medical treats second type 2 diabetes patient in IDE trial of investigational PIMA procedure